Introduction

42
The presence and fate of pharmaceutically active compounds (PhACs) in urban wastewater is 43 of substantial environmental concern due to their widespread occurrence [1] . It has been 44 repeatedly observed that conventional wastewater treatment is unable to sufficiently eliminate 
56
DCF and CBZ were observed to have adverse impacts on rainbow trout (Oncorhynchus 57 mykiss) and zebrafish, respectively [16] [17] [18] . However, research into chronic health impacts of catalysis [24] . The formation of pharmaceutical degradation products by AOPs has also been 65 identified as a challenge, as degradation products may be more toxic than the parent 66 compounds. Ultraviolet (UV) light irradiation is a widely used process for disinfection of 67 drinking water [25] , and is a promising process for wastewater purification. The photolytic 68 reaction mechanism is especially complicated as it may involve a number of different 69 reaction pathways forming many unknown degradation products. Some photolytic 70 degradation products of UV treatment may be more toxic than, or at least as toxic as, their 71 parent compounds [26] . Many common pharmaceutical compounds are susceptible to 72 degradation by UV at typical disinfection doses [27, 28] . Experiments have shown that DCF 73 and SMX are well degraded during UV photolysis and UV/H 2 O 2 treatment [29] . On the other 74 hand, low rates of removal of CBZ have been observed during photo-degradation [30, 31] .
75
Whilst its degradation rates are low, the major photolytic degradation products formed, 76 acridine and acridone, are known to be more toxic than their parent compound, possessing 77 considerable mutagenic and carcinogenic characteristics [26, [32] [33] [34] . The combination of UV • OH, which is strong oxidant, can attack a wide range of organic compounds 81 causing degradation through a series of steps including hydroxylation and dehydrogenation
82
[23].
83
Photo-degradation reactions can occur directly and indirectly [35, 36] . In direct photo-84 degradation, a compound absorbing radiation can become unstable and consequently decay, 85 whereas the indirect pathway involves naturally occurring compounds that produce strong 86 reactive species (such as singlet oxygen, and/or hydroxyl radicals) that then react with 87 organic compounds. The photolytic degradation products formed may have molecular 88 weights lower than their parent compounds [30, 37, 38] . Conversely the detected photolytic 89 degradation products could be observed with slightly higher molecular weights than their 90 parent compounds, as a result of radical additions rather than direct photolysis [30, 37] .
91
Additionally, photolytic degradation products with significantly larger molecular weights, 92 such as the formation of dimers, can be produced during irradiation through 93 photopolymerization [39, 40] . In general, the degradation products formed tend to display 94 different reactivity within the system to those of their parent compounds. However, research 95 conducted into the identification of these degradation products is limited. Consequently,
96
further investigation is required to fully elucidate the UV photolysis and UV/H 2 O 2 97 degradation of PhACs.
98
The overarching purpose of our work was to comprehensively investigate the degradation of 99 four pharmaceuticals, namely, diclofenac (DCF), sulfamethoxazole (SMX), carbamazepine 100 (CBZ), and trimethoprim (TMP), by UV photolysis and UV/H 2 O 2 advanced oxidation 101 process. The scope of this current paper was to analyse the range of degradation products 102 formed and identify previously unreported degradation products. Additionally, to confirm the 103 structure, where possible, of compounds previously reported using m/z ratio and mass 104 fragmentation. This also involved investigating the rate of degradation of the four (parent) 105 pharmaceuticals and the evolution of major degradation products. In addition, the toxicity of 106 the treated solutions was tested in a typical bacteria toxicity assay in order to evaluate the 107 relative toxicity of the mixture of degradation products compared to their parent compounds. 
Materials and Methods
109
Materials and chemicals
110
Four pharmaceuticals were selected for investigation in this study: diclofenac (DCF), 111 sulfamethoxazole (SMX), carbamazepine (CBZ), and trimethoprim (TMP) (Fig. 1) 
Experimental protocol
139
Stock solutions containing 5 g/L of DCF, SMX, CBZ, and TMP were prepared using pure 140 methanol. These were stored in amber bottles and kept in a freezer at -18ºC prior to use. For concentration was directly added to the solution prior switching the UV light on.
153
The sensitivity of the analysis for the identification of the degradation products was increased 154 by pre-concentrating with SPE cartridges. Sep-Pak cartridges (C18 6 cc Vac; 500 mg sorbent 155 per cartridge; 55-105 µm particle size) were purchased from Waters (Rydalmere, NSW,
156
Australia). The cartridges were first pre-conditioned with a 7 mL dichloromethane and 157 methanol mixture (1:1 v/v), 7 mL of methanol, followed by 7 mL of Milli-Q water. Then, the 158 samples were loaded onto the cartridges at a flow rate of 1-5 mL/min. The extracted 159 degradation products were eluted from the cartridge using 5 mL of methanol at a flow rate of 
Toxicity assessment
183
The toxicity of sample solutions before and after the treatment was evaluated using the 184 bacterial luminescence toxicity screen (BLT-Screen) [42] .The samples were treated using 185 UV only or UV/H 2 O 2 for the desired UV exposure time and H 2 O 2 amount. Then, the treated 186 and untreated solutions were extracted using SPE cartridges (as described above) and eluted 187 using 3 mL methanol, for an SPE enrichment factor of 100. A detailed description of the the best of our knowledge (Table 1) . The DCF degradation products were eluted through the A number of the newly detected photolytic DCF degradation products #11, 12, 14, and 15 270 were proposed to be formed via dimerization. The formation of other dimer DCF degradation 271 products during UV irradiation of DCF has been reported previously elsewhere [40, 43] .
272
The irradiation of DCF using LP-UV mercury lamp leads to sequential elimination of the 273 chlorine substituents within the DCF structure, followed by ring closure to form carbazole-1-274 acetic acid, which is considered the primary photolytic degradation product. The primary 275 photolytic DCF compound #1 has been previously identified in a number of studies [43] [44] [45] [46] . (Fig. 6 ). Peaks with S/N ratio of < 10 were ignored. 295 The evolution of DCF and its major photolytic degradation products was observed during UV 296 photolysis (Fig. 7) indicate that these degradation products were formed directly from DCF whereas, the other Therefore, these secondary degradation products, which contain some dimers, seemed to be 308 highly resistant toward UV photolysis. 
Sulfamethoxazole
310
The UV photolysis of SMX in pure water generated twelve photolytic degradation products 311 (Table 2 ). The majority of these degradation products (compounds #3 -12) were reported as 312 SMX UV photolytic degradation products for the first time in this study. Compounds #1 and 313 2 have been previously reported elsewhere [49, 50] (Fig. 8) . Similar to DCF degradation 314 products, the detected SMX photolytic degradation products were eluted through the LC-MS 315 column at different retention times based on their hydrophobicity. All the photolytic SMX 316 degradation products were formed at low concentrations, except compound #1, which was 317 considered to be the primary photolytic SMX degradation product. Peaks with S/N ratio of < 10 were ignored. 322
318
The UV photolysis of SMX in aqueous solution undergoes several reaction pathways, the reported to be 98 amu, as a result of a cleavage in the sulfur-nitrogen bond within the 337 structure of compound #1 (Fig. 8) . The degradation of SMX and formation of its major photolytic degradation products was 345 determined during UV photolysis (Fig. 9) . SMX had only one major degradation product 346 whilst all the other degradation products were formed at low concentrations. SMX began to 347 sharply degrade as soon as it was exposed to UV, leading to the formation of SMX major 348 photolytic degradation product, compound #1. This compound reached its maximum 
Carbamazepine
356
The UV photolysis and UV/H 2 O 2 of 5 mg/L CBZ in pure water produced more than eighteen
357
CBZ degradation products. Eight of these degradation products (compounds #3, 9, 12, 13, 14, 358 15, 17, and 18) are reported for the first time in this study ( (Fig. 10) .
401
The fragmentation patterns obtained by MS of compound #10 in this study confirm the 
Trimethoprim
419
The UV photolysis and UV/H 2 O 2 of 5 mg/L TMP in Milli-Q water produced more than 11 420 TMP degradation products, including five major ones (Table 4) . Three TMP degradation 421 products (#5, 7 and 11) are reported for the first time, including compound #5, which was a 7, 10, and 11). On the other hand, the degradation products reported during both UV only and 429 also when combining UV with a low level (0.01 g/L) of H 2 O 2 (i.e #1, 2, and 6) were only 430 detected at these conditions. At the higher H 2 O 2 amounts, compounds #1, 2, and 6 were not isomers at m/z = 323 were found, which was consistent with a previous study under different 435 conditions [54] . Additionally, there were a number of very small peaks that had signal-to 436 noise ratio less than 10 and did not meet the criteria for further analysis. (Fig. 12) . The evolution of the main TMP degradation products during UV photolysis and UV with a 476 different concentration of H 2 O 2 was determined (Fig. 13) . During UV photolysis, the major 477 TMP degradation products were compounds #1 and 2, which were formed as TMP was 478 gradually degraded (Fig. 13A ). Approximately 75% of 5 mg/L TMP was removed after 90 479 min of UV exposure. However, the photolytic degradation products did not show any (Fig. 13B-D) . The three 483 degradation products were produced at similar concentrations for all H 2 O 2 amounts used, 
Photolytic solution toxicity
503
The toxicity of the four pharmaceuticals and their degradation product mixtures during UV 504 photolysis and UV/H 2 O 2 were evaluated (Table 5 ). None of the tested parent compounds 505 were toxic in the BLT-Screen at the concentration tested (all <0.6 rTU at 5 mg/L), but most 506 (DCF, CBZ and SMX) showed an increased level of toxicity after UV treatment, most likely 507 as a result of more toxic photolytic degradation products in the solution. The toxicity of the 508 DCF solution increased dramatically from <0.6 to 6.7-7.2 rTU after 3, 5, and 10 min of UV 509 exposure, during a time window when the sample contained six degradation products at 510 relatively high concentrations (Fig. 7) . Applying a high H 2 O 2 dose (i.e. 0.12 g/L) and a long of CBZ reduced the solution toxicity again to below the detection limit of the assay (<0.6 517 rTU). The SMX solution toxicity showed slightly elevated toxicity (0.7 rTU) after 3 min of 518 UV exposure compared to below detection limit (<0.6 rTU) for untreated SMX solution. In 519 contrast, the TMP solution showed no change in toxicity during UV exposure, or when 520 combined with H 2 O 2 (all <0.6 rTU). Therefore, although UV treatment may lead to the 521 formation of toxic degradation products for DCF, in particular, but also CBZ and SMX, the 522 combination with H 2 O 2 effectively degraded them into less toxic degradation products. 
Conclusion
531
This work provides further insights to the UV photolysis and UV/H 2 O 2 of DCF, SMX, DCF, 532 and TMP. DCF and SMX were easily degraded to below their LC-MS detection limit (1 533 µg/L) after only 8 min of exposure to UV photolysis, and there was no need to combine UV 534 with H 2 O 2 to improve their removal. However, the addition of H 2 O 2 may be essential during 535 UV photolysis of DCF to avoid the formation of toxic degradation products during UV alone.
536
CBZ and TMP were quite resistant to UV photolysis, whereas, the combination of UV with 
